KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to 0.0.

  • Inovio Pharmaceuticals' Asset Utilization Ratio rose 5687.52% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 5687.52%. This contributed to the annual value of 0.0 for FY2024, which is 5215.14% down from last year.
  • Inovio Pharmaceuticals' Asset Utilization Ratio amounted to 0.0 in Q3 2025, which was up 5687.52% from 0.0 recorded in Q2 2025.
  • Over the past 5 years, Inovio Pharmaceuticals' Asset Utilization Ratio peaked at 0.04 during Q2 2023, and registered a low of 0.0 during Q3 2024.
  • Its 5-year average for Asset Utilization Ratio is 0.01, with a median of 0.0 in 2023.
  • Per our database at Business Quant, Inovio Pharmaceuticals' Asset Utilization Ratio surged by 87197.36% in 2023 and then crashed by 8830.8% in 2024.
  • Inovio Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 705.63% to 0.03 in 2022, then tumbled by 83.51% to 0.0 in 2023, then plummeted by 56.74% to 0.0 in 2024, then surged by 34.01% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.0 during Q1 2025.